[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340094-105":59,"doc-detail-340094-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","immune-related-long-non-coding-rna-signature-determines-prognosis-and-immunotherapeutic-coherence-in-esophageal-cancer","Immune-Related Long Non-Coding RNA Signature Determines Prognosis and Immunotherapeutic Coherence in Esophageal Cancer","","A study investigates immune-related long non-coding RNAs (lncRNAs) with prognostic value for esophageal cancer and builds a risk-score model to improve prognosis and immunotherapeutic coherence. RNA-seq data from 162 esophageal cancer patients and 11 non-cancer individuals plus clinical information from TCGA were analyzed using differential expression, co-expression, Kaplan–Meier, Cox proportional hazards, and ROC analyses. A 12-lncRNA signature distinguished low- and high-risk groups, associated with immune cell infiltration patterns and immune checkpoint inhibitor marker expression.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/immune-related-long-non-coding-rna-signature-determines-prognosis-and-immunotherapeutic-coherence-in-esophageal-cancer/340094/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/immune-related-long-non-coding-rna-signature-determines-prognosis-and-immunotherapeutic-coherence-in-esophageal-cancer/340094.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the primary goal of this study?","Question",{"text":113,"@type":114},"To identify immune-related lncRNAs that can predict prognosis and to establish a risk-score model for better outcomes and immunotherapeutic coherence in esophageal cancer patients.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were the immune-related lncRNAs evaluated and validated?",{"text":118,"@type":114},"The study analyzed TCGA RNA-seq expression and clinical data using differential expression and co-expression analyses, then applied Kaplan–Meier and Cox proportional hazards models, with ROC evaluation of the risk model performance across cohorts.",{"name":120,"@type":111,"acceptedAnswer":121},"What immune-related differences were observed between low- and high-risk groups?",{"text":122,"@type":114},"Low-risk patients showed enriched infiltration of naive B cells, resting regulatory T cells, memory T cells, and plasma cells, while high-risk patients had higher enrichment of tumor-associated M2 macrophages, alongside pathway associations including inflammatory and JAK-STAT signaling.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},340094,1790162274,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":36,"preview_page_count":19,"preview_urls":146},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Immune-Related Long Non-Coding RNA Signature Determines Prognosis and Immunotherapeutic Coherence in Esophageal Cancer  \nVivek Uttam1, Harmanpreet Singh Kapoor2 , Manjit Kaur Rana3 , Ritu Yadav1, Hridayesh Prakash4 , Manju Jain5 , Hardeep Singh Tuli6 and Aklank Jain1  \n1Non-Coding RNA and Cancer Biology Lab, Department of Zoology, Central University of Punjab, Ghudda, Punjab, India . 2 Department of Mathematics and Statistics, Central University of Punjab, Ghudda, Punjab, India . 3 Department of Pathology/Lab Medicine, AIIMS, Bathinda, Punjab, India .  \n4Amity Centre of Translational Research, Noida, India . 5 Department of Biochemistry, Central University of Punjab, Ghudda, Punjab, India . 6 Department of Biotechnology, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Haryana, India .  \nCancer Informatics Volume 23: 1–16  \n© The Author(s) 2024  \nArticle reuse guidelines: [sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/11769351241276757](DOI: 10.1177/11769351241276757)  \n|  |  |\n| --- | --- |\n| ABSTRACT\u003Cbr>OBjECTIvES: Aim of this study was to explore the immune-related lncRNAs having prognostic role and establishing risk score model for better prognosis and immunotherapeutic coherence for esophageal cancer (EC) patients .\u003Cbr>METhODS: To determine the role of immune-related lncRNAs in EC, we analyzed the RNA-seq expression data of 162 EC patients and 11 non-cancerous individuals and their clinically relevant information from the cancer genome atlas (TCGA) database. Bioinformatic and statistical analysis such as Differential expression analysis, co-expression analysis, Kaplan Meier survival analysis, Cox proportional hazards model, ROC analysis of risk model was employed.\u003Cbr>RESuLTS: Utilizing a cutoff criterion (log2FC > 1 + log2FC \u003C −1 and FDR \u003C 0. 01), we identified 3737 RNAs were significantly differentially expressed in EC patients . Among these, 2222 genes were classified as significantly differentially expressed mRNAs (demRNAs), and 966 were significantly differentially expressed lncRNAs (delncRNA) . Through Pearson correlation analysis between differentially expressed lncRNAs and immune related-mRNAs, we identified 12 immune-related lncRNAs as prognostic signatures for EC. Notably, through Kaplan-Meier analysis on these lncRNAs, we found the low-risk group patients showed significantly improved survival compared to the high-risk group. Moreover, this prognostic signature has consistent performance across training, testing and entire validation cohort sets . Using ESTIMATE and CIBERSORT algorithm we further observed significant enriched infiltration of naive B cells, regulatory T cells resting CD4+ memory T cells, and, plasma cells in the low-risk group compared to high-risk EC patients group. On the contrary, tumor-associated M2 macrophages were highly enriched in high-risk patients . Additionally, we confirmed immune-related biological functions and pathways such as inflammatory, cytokines, chemokines response and natural killer cell-mediated cytotoxicity, toll-like receptor signaling pathways, JAK-STAT signaling pathways, chemokine signaling pathways significantly associated with identified IRlncRNA signature and their co-expressed immune genes . Furthermore, we assessed the predictive potential of the lncRNA signature in immune checkpoint inhibitors; we found that programed cell death ligand 1 (PD-L1; P-value = . 048), programed cell death ligand 2 (PD-L2; P-value = . 002), and T cell immunoglobulin and mucin-domain containing-3 (TIM-3; P-value = . 045) expression levels were significantly higher in low-risk patients compared to high-risk patients .\u003Cbr>CONCLuSION: We believe this study will contribute to better prognosis prediction and targeted treatment of EC in the future.\u003Cbr>KEywORDS: Esophageal cancer, TCGA, immune-related lncRNA, immune checkpoint blockade, prognosis, immune cell infiltration |  |\n| RECEIvED: April 1, 2024. ","cbCaiauD017rCcim","https://ap.wps.com/l/cbCaiauD017rCcim","pdf",8025197,16,"English","# Abstract\n## Objectives\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the primary goal of this study?\",\"answer\":\"To identify immune-related lncRNAs that can predict prognosis and to establish a risk-score model for better outcomes and immunotherapeutic coherence in esophageal cancer patients.\"},{\"question\":\"How were the immune-related lncRNAs evaluated and validated?\",\"answer\":\"The study analyzed TCGA RNA-seq expression and clinical data using differential expression and co-expression analyses, then applied Kaplan–Meier and Cox proportional hazards models, with ROC evaluation of the risk model performance across cohorts.\"},{\"question\":\"What immune-related differences were observed between low- and high-risk groups?\",\"answer\":\"Low-risk patients showed enriched infiltration of naive B cells, resting regulatory T cells, memory T cells, and plasma cells, while high-risk patients had higher enrichment of tumor-associated M2 macrophages, alongside pathway associations including inflammatory and JAK-STAT signaling.\"}]","Immune-Related Long Non-Coding RNA Signature Determines Prognosis and Immunotherapeutic Coherence in Esophageal Cancer | PDF",1790034157,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2bf5fef2f0b368b90dbac1097513919b.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/896bf3ca34deb2d40e13c150af1164c1.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45175587c45a6f69f5459ffb0305ff63.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4fd20141e0579be9947a8ab0234ac9f0.webp",980,1385]